Skip to content

Therapeutic Outcomes of 2940 nm Er:YAG Fractional Laser in Periorbital Rejuvenation

Therapeutic Outcomes of 2940 nm Er:YAG Fractional Laser in Periorbital Rejuvenation

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500106862
Enrollment
Unknown
Registered
2025-07-31
Start date
2025-08-08
Completion date
Unknown
Last updated
2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

The skin around the orbit aged

Interventions

The side being treated group:During the treatment with 2940nm erbium fractional laser, the wavelength was selected as 2940nm, the depth of action was 6-50um, and the spot size was chosen as 4mm. The t
Control group:Placebo

Sponsors

The First Affiliated Hospital of Xiamen University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 60 Years

Inclusion criteria

Inclusion criteria: (1) Gender is not limited, and the age range is from 20 to 60 years old; (2) Patients with varying degrees of wrinkles, loose skin or pigmentation around the eyes who require eye area rejuvenation treatment; (3) Express voluntary cooperation for this test.

Exclusion criteria

Exclusion criteria: (1) Patients who have suffered from benign or malignant skin tumors; (2) Patients who have previously developed hypertrophic scars or keloids; (3) Patients with skin diseases such as eczema, psoriasis, and skin infections that may interfere with the efficacy of laser treatment or increase the risk of complications; (4) Patients with photosensitive diseases such as systemic lupus erythematosus, or those who have been using photosensitive drugs for a long time; (5) Patients who have received any injection treatment in the periorbital area within the past year, undergone any ocular plastic surgery within the past two years, or received any local treatment in the periorbital area other than prescribed topical ointments; (6) Female patients who are pregnant or breastfeeding; (7) Patients with mental and cognitive disorders as well as other factors that affect treatment compliance.

Design outcomes

Primary

MeasureTime frame
Lemperle Wrinkle score;Fitzpatrick Classification of wrinkles;The Merz Scales points-scoring system;

Secondary

MeasureTime frame
Satisfaction survey;

Countries

China

Contacts

Public ContactJiapeng Yin

The First Affiliated Hospital of Xiamen University

asoun@126.com+86 139 5920 1020

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026